Year,Rank_nr,Company,Industry,Country,Sales,Profits,Assets,Market_Value,ï»¿Rank_nr
2015,,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,751.0,-134.0,2490.0,18902.0,1820.0
2016,,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,877.0,-171.8,3729.0,15157.0,1894.0
2017,,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1113.0,-642.2,4024.0,15204.0,1930.0
2018,,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1400.0,-144.9,4597.0,15623.0,1999.0
2020,,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1788.0,114.0,4723.0,16557.0,1916.0
2021,,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1842.0,859.1,5848.0,14437.0,1453
